Determination of recombinant biological agents requirement for patients with rheumatoid arthritis: development of standardized indications for prescription
60 Recombinant biological agents (RBA) are perspective medications for treatment of rheu- matoid arthritis (RA) but their wide administration is hampered by high cost. State paysfor treatment with RBA in Russia. Information about number of pts requiring biological therapy is necessary for planning a...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2009-12-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/812 |